Allergy

AGY.L

Tags: GB Healthcare Drug Manufacturers - Specialty & Generic

Allergy Therapeutics plc Price (AGY.L)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

3,743,332,000

(458.4104)%

Market Cap of Allergy (AGY.L)

Market cap:

As of , AGY.L has a market cap of . This makes AGY.L the 450th most valuable company in the GB by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pet... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.067-8
Market Cap 333.65M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

ceo: Mr. Manuel Llobet
IPO Date: October, 11, 2004
Country: GB
Currency: GBp
Headquaters: No Data
Employees: 612

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: